leadf
logo-loader
viewXPhyto Therapeutics Corp.

Full interview: XPhyto sees Germany as key market as they announce deal with Oettinger Brauerei

XPhyto (CSE: XPHY- OTC: XPHYF) CEO Hugh Rogers and Bunker, Managing Director Wolfgang Probst joined Steve Darling from Proactive Vancouver to share news the company has signed a deal with German Brewer Oettinger development, production, and distribution of cannabis-infused beverages and products.

Rogers telling Proactive how big the market in German and the advantages of being a first mover, Probst discussed what type of products they will be creating and distributing.

Quick facts: XPhyto Therapeutics Corp.

Price: 1.8 CAD

CSE:XPHY
Market: CSE
Market Cap: $104.42 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of XPhyto Therapeutics Corp. named herein, including the promotion by the Company of XPhyto Therapeutics Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

XPhyto Therapeutics subsidiary Vektor Pharma develops oral disintegrating...

XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF) (FRA:4XT) CEO Hugh Rogers tells Proactive the group's German subsidiary Vektor Pharma TF GmbH has developed an oral disintegrating film (ODF) drug delivery mechanism for a major European generic drug company. Rogers says during the third...

1 week, 1 day ago

2 min read